The Global Adhesion Barrier Market was valued at USD 793.99 Million in 2020 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.02% between 2021 to 2028. Rise in the number of injuries & surgeries and increasing awareness about adhesion related diseases and adhesion formation are driving the market for adhesion barrier. Moreover, there are different complication that arise after surgeries like in case of abdominal surgeries there are chances of abdominal pain, or in case of gynaecological surgery the women infertility is most commonly observed. Hence, due to increasing awareness the patients are more concerned and the demand for products of adhesion barriers is increasing.
Whereas, the major factor that is obstructing the market growth for Adhesion Barrier are due to lack of reliability and evidence to support the efficacy and safety of the products of adhesion barriers.
Due to COVID-19 there has been restrictions imposed all across the globe and many governments have implemented strict rules and regulations. This has decreased mobility and also there has been a decrease in the number of surgical procedures. Hence, the growth of this market has slowed down.
The Adhesion Barrier Market in segmented on the basis of product the adhesion barrier market is bifurcated into hyaluronic acid, regenerative cellulose, polyethylene glycol, collagen & protein and fibrin. Also, on the basis of applications the market is bifurcated into orthopedics, gynaecological surgery, abdominal and cardiovascular. Moreover, the segmentation ok basis of type divides the target market into gel, film and liquid.
Asia-Pacific region is expected to grow at a high rate over the coming years and is the dominating region. This is attributable to the large population and rising demand for health care industry. Moreover, the diseases are rising at a high rate in the countries with growing population like India and China. Furthermore, the expansion of private sector hospitals in remote areas and demand for surgical instruments is expected to grow the market.
Some of the major players operating in the global Adhesion Barrier includes Terumo Corporation, Atrium Medical Corporation, and Becton, Dickinson and Company, Anika Therapeutics, Johnson & Johnson (J&J), MAST Biosurgery, Innocoll, Betatech Medical, CorMatrix Cardiovascular, Inc., W.L. Gore & Associates, and Allosource, Baxter International, Integra LifeSciences, BiosCompass and FzioMed, among others.